Shockwave Dose for Adhesive Capsulitis

Study on the Dose of Extracorporeal Shockwave Therapy for Treating Adhesive Capsulitis

The investigators evaluated the therapeutic efficacy of different shockwave dosages for adhesive capsulitis and further examined the temporal effects and subgroup responses based on baseline range of motion

The study compares two different shockwave treatment doses, each delivered as a single session to patients with adhesive capsulitis of the shoulder. We will measure shoulder range of motion before and after treatment and assess functional improvement using the Constant-Murley score. Finally, we will analyze changes in joint mobility at various post-treatment time intervals to evaluate the therapeutic effectiveness of the two shockwave dosing protocols.

Inclusion Criteria:

• patient age ≥ 20 years
• first episode of adhesive capsulitis
• persistent shoulder pain with restricted motion for ≥ 3 months
• prior management limited to analgesic medications
• active abduction in the scapular plane ≤ 135°

Exclusion Criteria:

• shoulder or cervical pathology
• history of shoulder fracture, infection, or tumor
• previous shoulder surgery
• pacemaker presence
• pregnancy
• coagulopathy
• inability to complete follow-up assessments